Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$65,583,435
-$1,211,261 QoQ
Shares Held
258,233
-5.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#391
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $293,455,653 across 12 Drug Manufacturers - General names. JNJ ranks #2 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
336,097 | $84,575,449 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
258,233 | $65,583,435 | |
| 3 | MRK |
Merck & Co., Inc.
|
447,832 | $57,546,412 | |
| 4 | LLY |
ELI LILLY & Co
|
24,659 | $29,576,746 | |
| 5 | NVS |
Novartis AG
|
79,360 | $12,437,299 | |
| 6 | PFE |
Pfizer Inc
|
465,004 | $11,197,296 | |
| 7 | SNY |
Sanofi
|
195,567 | $8,342,888 | |
| 8 | AMGN |
Amgen Inc
|
21,433 | $7,761,317 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,583,435 | 258,233 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $66,794,696 | 273,256 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $58,478,896 | 282,575 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $52,536,346 | 283,337 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $43,949,841 | 287,724 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $49,572,726 | 298,919 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $46,795,994 | 323,579 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $53,188,578 | 328,203 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $48,366,828 | 330,917 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $52,580,774 | 332,390 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $57,094,269 | 364,261 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $57,798,357 | 371,097 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $63,230,957 | 382,014 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $59,365,465 | 383,003 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $68,659,968 | 388,678 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $63,872,289 | 390,991 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $70,097,633 | 394,894 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $68,523,498 | 386,636 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,301,599 | 387,570 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $61,821,392 | 382,795 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $63,512,871 | 385,534 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $72,053,833 | 438,417 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $69,876,405 | 443,998 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $66,885,977 | 449,261 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $68,912,356 | 490,026 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $63,748,193 | 486,145 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||